Updates are available Correction dated 2018-04-01
Click to view Correction: https://doi.org/10.1038/nm0418-525b
-
Authors
Velardi, Enrico
Tsai, Jennifer J
Radtke, Stefan https://orcid.org/0000-0002-2842-4820
Cooper, Kirsten
Argyropoulos, Kimon V
Jae-Hung, Shieh
Young, Lauren F
Lazrak, Amina
Smith, Odette M
Lieberman, Sophie
Kreines, Fabiana
Shono, Yusuke
Wertheimer, Tobias
Jenq, Robert R
Hanash, Alan M https://orcid.org/0000-0002-3273-3634
Narayan, Prema
Lei, Zhenmin
Moore, Malcolm A
Kiem, Hans-Peter
van den Brink, Marcel R M
Dudakov, Jarrod A https://orcid.org/0000-0001-6220-5632
- License Information
-
More Information
Article History
Received: 21 July 2016
Accepted: 13 December 2017
First Online: 8 January 2018
Change Date: 22 January 2018
Change Type: Corrigendum
Change Details: In the version of this article initially published online, the phrase "<i>ex vitro</i>" appears in the abstract. This should be "<i>ex vivo</i>". The error has been corrected in the print, PDF and HTML versions of this article.
Change Date: 1 April 2018
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/nm0418-525b
Competing interests
: A provisional patent application has been filed on the use of LHRH-Ant as a treatment for hematopoietic recovery from radiation injury (US 15/033,178), with E.V., J.A.D., and M.R.M.v.d.B. listed as inventors. A provisional patent application has been filed on the use of LH to create, ablate, and modify primitive stem cell populations (US 62/566,897), with E.V., J.A.D., S.R., H.-P.K., and M.R.M.v.d.B. listed as inventors.
